189 related articles for article (PubMed ID: 30593624)
1. A Cell Culture Model for Persistent HCV Infection.
Castro V; Ávila-Pérez G; Mingorance L; Gastaminza P
Methods Mol Biol; 2019; 1911():157-168. PubMed ID: 30593624
[TBL] [Abstract][Full Text] [Related]
2. How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection?
Maggi F; Focosi D; Pistello M
Curr Drug Targets; 2017; 18(7):811-825. PubMed ID: 26245474
[TBL] [Abstract][Full Text] [Related]
3. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
4. Mathematical modeling of hepatitis C RNA replication, exosome secretion and virus release.
Zitzmann C; Kaderali L; Perelson AS
PLoS Comput Biol; 2020 Nov; 16(11):e1008421. PubMed ID: 33151933
[TBL] [Abstract][Full Text] [Related]
5. Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles.
Hu L; Li J; Cai H; Yao W; Xiao J; Li YP; Qiu X; Xia H; Peng T
Antiviral Res; 2017 Dec; 148():5-14. PubMed ID: 29074218
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
Chung RT; He W; Saquib A; Contreras AM; Xavier RJ; Chawla A; Wang TC; Schmidt EV
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9847-52. PubMed ID: 11493707
[TBL] [Abstract][Full Text] [Related]
7. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.
Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847
[TBL] [Abstract][Full Text] [Related]
8. N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
Schweitzer CJ; Zhang F; Boyer A; Valdez K; Cam M; Liang TJ
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118118
[TBL] [Abstract][Full Text] [Related]
9. A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture.
Oraby AK; Gardner CL; Needle RF; Kofahi HM; Everard KR; Taylor NGA; Rutihinda SG; Barry JP; Hirasawa K; Georghiou PE; Russell RS
Microbiol Spectr; 2021 Sep; 9(1):e0043921. PubMed ID: 34319169
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-mediated interactions between host and hepatitis C virus.
Li H; Jiang JD; Peng ZG
World J Gastroenterol; 2016 Jan; 22(4):1487-96. PubMed ID: 26819516
[TBL] [Abstract][Full Text] [Related]
12. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
Bukh J
J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus: Enslavement of host factors.
Sharma G; Raheja H; Das S
IUBMB Life; 2018 Jan; 70(1):41-49. PubMed ID: 29281185
[TBL] [Abstract][Full Text] [Related]
14. The science of direct-acting antiviral and host-targeted agent therapy.
Pawlotsky JM
Antivir Ther; 2012; 17(6 Pt B):1109-17. PubMed ID: 23188746
[TBL] [Abstract][Full Text] [Related]
15. Counteraction of HCV-Induced Oxidative Stress Concurs to Establish Chronic Infection in Liver Cell Cultures.
Anticoli S; Amatore D; Matarrese P; De Angelis M; Palamara AT; Nencioni L; Ruggieri A
Oxid Med Cell Longev; 2019; 2019():6452390. PubMed ID: 30906503
[TBL] [Abstract][Full Text] [Related]
16. Treating hepatitis C infection by targeting the host.
Salloum S; Tai AW
Transl Res; 2012 Jun; 159(6):421-9. PubMed ID: 22633094
[TBL] [Abstract][Full Text] [Related]
17. Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes.
Grünvogel O; Colasanti O; Lee JY; Klöss V; Belouzard S; Reustle A; Esser-Nobis K; Hesebeck-Brinckmann J; Mutz P; Hoffmann K; Mehrabi A; Koschny R; Vondran FWR; Gotthardt D; Schnitzler P; Neumann-Haefelin C; Thimme R; Binder M; Bartenschlager R; Dubuisson J; Dalpke AH; Lohmann V
Gastroenterology; 2018 Jun; 154(8):2237-2251.e16. PubMed ID: 29535029
[TBL] [Abstract][Full Text] [Related]
18. Novel insights into hepatitis C virus replication and persistence.
Bartenschlager R; Frese M; Pietschmann T
Adv Virus Res; 2004; 63():71-180. PubMed ID: 15530561
[TBL] [Abstract][Full Text] [Related]
19. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
Guedj J; Neumann AU
J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
[TBL] [Abstract][Full Text] [Related]
20. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]